Bruce Donald is the James B. Duke Distinguished Professor of Computer Science, Mathematics, and Chemistry, and Professor of Biochemistry in the School of Medicine. He received a B.A. from Yale University, and a Ph.D. from the MIT Artificial Intelligence Laboratory. Donald was a professor in the Computer Science Department at Cornell University from 1987-1998. In the 1990's, he worked at Paul Allen's tech company, Interval Research Corporation. More recently, Donald founded Gavilán BioDesign (now Ten63 Therapeutics).
Therapeutics and vaccines designed in Donald's papers are currently in 34 clinical trials, with promising results recently reported in The Lancet. Dr. Donald is the author of "Algorithms in Structural Molecular Biology" (MIT Press), a widely-used textbook covering computational and experimental studies of protein structure and design. He received a Presidential Young Investigator Award, and was named a Guggenheim Fellow for his work on algorithms for structural proteomics. Donald is a Fellow of the ACM, Fellow of the AAAS, and Fellow of the IEEE. The Donald lab is supported by an NIH Outstanding Investigator Grant. Donald has supervised over 50 PhD students and Post-Docs, many of whom are now independent researchers at R1 Universities, in Pharma, and at National Labs.
